AzTrials
AzTrials

Rib FractureNCT06757803

The Analgesic Effect of Retro-laminar Block Versus Paravertebral Block in Patients With Multiple Fracture Ribs

A study testing rertrolaminar block and paravertebral block in people with Rib Fracture, run by Assiut University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Rib fractures are a common injury, occurring in up to 10% of all trauma patients. Multiple rib fractures can be particularly painful and debilitating, making it difficult for patients to breathe and cough. This can lead to complications such as atelectasis, pneumonia, and respiratory failure. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Rib Fracture
What is being tested?
rertrolaminar block and paravertebral block
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteEgypt
Study dates
12 Dec 2024to 19 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • * Age 18 years or older
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Rib fractures, as confirmed by X-ray or computed tomography (CT) scan
  • Both sexes, males and females.

Who cannot join

  • *Patient refusal.
  • Infection at the injection site
  • Allergy to local anesthetics
  • Neurological deficit
  • Spinal deformity

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Assiut University Hospital

    Asyut

Other trials in Egypt

About this study

Rib fractures are a common injury, occurring in up to 10% of all trauma patients. Multiple rib fractures can be particularly painful and debilitating, making it difficult for patients to breathe and cough. This can lead to complications such as atelectasis, pneumonia, and respiratory failure.

Adequate pain control is essential for patients with rib fractures. This can help to improve respiratory function, reduce the risk of complications, and speed up recovery.

Read more

Paravertebral block (PVB) is a regional anaesthetic technique that is commonly used for pain management in patients with rib fractures. It involves injecting local anaesthetics into the paravertebral space, which is a region of tissue located between the transverse processes of the vertebrae and the pleura. PVB is an effective way to block the sensory nerves that supply the thoracic region, including the ribs.

However, PVB can be technically challenging to perform, and there is a risk of complications such as pneumothorax and pleural puncture.

Retrolaminar block (RLB) is a newer regional anaesthetic technique that has been proposed as an alternative to PVB for pain management in patients with rib fractures. RLB involves injecting local anaesthetics into the retrolaminar space, which is a region of tissue located between the lamina of the vertebra and the epidural space.

RLB is thought to be easier to perform than PVB, and there is a lower risk of complications. However, there is limited studies support the use of RLB for pain management in patients with rib fractures.

The primary objective of this research is to compare the analgesic efficacy of retrolaminar block (RLB) and paravertebral block (PVB) in patients with fracture ribs.

Secondary objectives include:

  • To compare the safety of RLB and PVB
  • To compare the duration of analgesia provided by RLB and PVB
Read the detailed description

Rib fractures are a common injury, occurring in up to 10% of all trauma patients. Multiple rib fractures can be particularly painful and debilitating, making it difficult for patients to breathe and cough. This can lead to complications such as atelectasis, pneumonia, and respiratory failure.

Adequate pain control is essential for patients with rib fractures. This can help to improve respiratory function, reduce the risk of complications, and speed up recovery.

Paravertebral block (PVB) is a regional anaesthetic technique that is commonly used for pain management in patients with rib fractures. It involves injecting local anaesthetics into the paravertebral space, which is a region of tissue located between the transverse processes of the vertebrae and the pleura. PVB is an effective way to block the sensory nerves that supply the thoracic region, including the ribs.

However, PVB can be technically challenging to perform, and there is a risk of complications such as pneumothorax and pleural puncture.

Retrolaminar block (RLB) is a newer regional anaesthetic technique that has been proposed as an alternative to PVB for pain management in patients with rib fractures. RLB involves injecting local anaesthetics into the retrolaminar space, which is a region of tissue located between the lamina of the vertebra and the epidural space.

RLB is thought to be easier to perform than PVB, and there is a lower risk of complications. However, there is limited studies support the use of RLB for pain management in patients with rib fractures.

Conditions
Rib Fracture
Being tested
rertrolaminar block, paravertebral block
Medical subject headings
Rib Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • rertrolaminar blockProcedure or surgery

    Positioning

    The patient is positioned in a lateral decubitus position with the affected side up. The patient's arm on the affected side is placed behind the head. The patient's spine is aligned and the shoulder is elevated to expose the paravertebral space.

    *Ultrasound imaging

    A high-frequency linear ultrasound probe (5-12 MHz) is placed in a paramedian sagittal plane at the desired level of block. The probe is oriented so that the transverse processes are visualized on the lateral side of the screen and the vertebral laminae are visualized on the medial side of the screen. The interlaminar space is visualized as a hypoechoic region between the laminae.

    *Needle insertion

    A short bevel block needle (20-22 G) is inserted through the skin at the caudal end of the ultrasound probe, aiming cephalad. The needle is advanced under real-time ultrasound guidance until the tip of the needle contacts the lamina. The needle is then slightly withdrawn and the local anesthetic is injected into t

  • paravertebral blockProcedure or surgery

    • Patient Preparation
    • Place the patient in the lateral decubitus position with the side of the block facing up.
    • Position the patient's arm so that it is resting comfortably on the operating table.
    • Prepare the skin over the block site with an antiseptic solution.
    • Sterilely drape the area.
    • Ultrasound Imaging
    • Place the ultrasound probe in a transverse plane at the level of the desired block.
    • Identify the following anatomical landmarks:
    • Vertebral body
    • Transverse process
    • Pleura
    • Intercostal space
    • Needle Insertion

    Use a sterile ultrasound-guided needle. Insert the needle in-plane from a lateral to medial direction, aiming for the apex of the paravertebral space.

    The needle should be advanced until it is just beyond the transverse process.

    *Test Aspiration

    Aspirate to ensure that the needle is not in a blood vessel.

    • Local Anesthetic Injection
    • Inject the local anesthetic slowly, aspirating frequently.
    • The local anesthetic should be injected int
Study groups in NCT06757803
Study groupRoleWhat they receive
group 1Experimentalpatients will be subjected to rertrolaminar block
Receives: Procedure: rertrolaminar block
group 2Experimentalpatients will be subjected to paravertebral block
Receives: Procedure: paravertebral block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. total post operative analgesic consumption

    total analgesic consumption in 1st 48hours

    Measured: 48 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jan 2025
  2. Study start12 Dec 2024
  3. Primary completion2 Dec 2025
  4. Study completion19 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06757803
Sponsor's protocol ID
RLB VS PVB fracture ribs
Status last verified
May 2026
First submitted
26 Dec 2024
Last updated
3 Jun 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Kotze A, Scally A, Howell S. Efficacy and safety of different techniques of paravertebral block for analgesia after thoracotomy: a systematic review and metaregression. Br J Anaesth. 2009 Nov;103(5):626-36. doi: 10.1093/bja/aep272.

    PubMed 19837806

Questions about this trial

What is this clinical trial studying?

A study testing rertrolaminar block and paravertebral block in people with Rib Fracture, run by Assiut University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

total post operative analgesic consumption (time frame: 48 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06757803, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in